Abstract
Introduction

Neurodegenerative disorders (NDD) constitute a set of pathological conditions originating from slow progressive and irreversible dysfunction and loss of neurons and synapses in selected areas of the nervous system which determine clinical presentation and course. The major basic mechanisms leading to neurodegeneration (ND) are considered multifactorial caused by genetic, environmental and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully
understood [1, 2] . NDDs currently are classified according to known genetic mechanisms and/or to the major compounds of their protein deposits (Fig. 1 ). Based on critical conformational changes of proteins, these disorders are denoted as 'protein misfolding' diseases or proteinopathies [3, 4] . Recent [14] [15] [16] . However, the precise biochemical mechanisms are poorly understood. [17] [18] [19] [20] (Fig. 2) . Soluble A␤ oligomers are increased in Alzheimer's disease (AD) in both brain tissue and plasma [21] , and their levels correlate with cognitive dysfunction [22] . The [27] . A␤ peptides have a crucial role in regulation of synapse vesicle release and might point to the primary pathological events that lead to compensatory synaptic loss in AD [28] . APLP1 forming heterodimers with APP and being mainly present on the cell surface, is a strong candidate receptor for (toxic) A␤ oligomers [29] . They affect the presynaptic and terminal post-synaptic region [30, 31, [424] [425] [426] , synaptic plasticity and transmission [32] correlating with synaptic loss [33] , and perturbated APP synaptic adhesion activity may contribute to synaptic dysfunction and AD pathogenesis [34, 35] . Native amylospheroids isolated from AD brains with a distinct toxic surface induce neuronal loss through a mechanism different from other A␤ assemblies, which have been reported to perturbate glutamatergic synapse transmission [36] . The amount of A␤ is determined by the balance between its production by proteolytic processing of APP via ␤-and ␥-secretases and its clearance. Apolipoprotein E 4 has been identified as an AD risk factor, partly explained by its reduced ability to crosslink A␤ [37] . Increased A␤ production and/or aggregation likely contribute to progression of AD [38] , while suppression of A␤ deposition leads to long-term reduction of AD pathology [39, 40] . [41] . Autoantibodies against A␤ are common in AD brain and help control the plaque burden [42] . The fraction of the soluble, mainly toxic A␤ pool is intracellular and is recognized and targeted by conformation-sensitive antibodies [43] . Single-domain antibodies recognize selectively small oligomeric forms of A␤, prevent A␤-induced neurotoxicity, and inhibit fibril formation [18] . Lipid surfaces promote aggregation of A␤ proteins and subsequent permeability changes on lipid membranes [44] , but there is a dynamic relationship between intra and extracellular pools of A␤ [45] , intraneuronal A␤ accumulation particularly contributing to AD progression [46] , to which changes at neuronal networks may strongly contribute [47] . A prion-like spread has been shown for A␤ aggregates in a tg mouse model [427] , and extrusion of A␤ aggregates may seed extracellular amyloid plaque formation during AD pathogenesis [428] .
'Toxic oligomer' hypothesis
A causative link between the formation of protein aggregates and ND is suggested to be a result of the toxic action of substances produced during early phases, i.e. soluble oligomers and protofibrillar derivatives of misfolded proteins
The 'toxic oligomer' hypothesis is supported by the finding that a single-domain antibody can recognize a common conformational epitope that is displayed by several disease-associated proteins, including ␤-amyloid (A␤), ␣-synuclein (␣Syn), protein, prions and polyglutamine (polyQ) peptides
analysis of the assembly pathway of A␤ in vitro and biochemical characterization of A␤ deposits isolated from AD brains indicate that A␤ oligomerization occurs via distinct intermediates. Recent studies suggest the existence of different types of A␤42 strains, some causing toxic effects and others aggregation into oligomers without adapting toxic conformations [23]. A␤40 inhibits amyloid deposition in vivo [24], but 3D reconstruction of A␤1-40 and A␤1-42 amyloid fibrils revealed similar protofibril structures [25]. The cellular prion protein (PrPC) and amyloid precursor protein (APP)-like protein 1 (APLP1) were suggested as possible mediators of A␤-induced synaptic dysfunction [26]. A␤ oligomers isolated from the brains of AD patients and injected into rodents are capable to disrupt N-methyl D-aspertate acid receptors and impairing memory
Recent results provide a unifying mechanism in which A␤ oligomers induce hyperphosphorylation in AD, while an antibody that targets soluble A␤ oligomers blocks their attachment to synaptic binding sites and prevents hyperphosphorylation
Oligomeric and pre-aggregated forms of protein have been shown to be toxic in vitro, but the mechanisms underlying its structural changes leading to human tauopathies still remain elusive [48, 49] . The natively unfolded character of and its aggregation to Alzheimer-like paired helical filaments and the link between A␤ and in this relationship in AD and other NDDs have been discussed conversely (coexistence of both, axonal connection; 'dual pathway' model - [40, 50] . Granular oligomers slowly evolve to larger structures and eventually to filaments having a size smaller than those for PHFs purified from AD [51] . Recent studies with that has been believed to reside within the cytoplasm, suggested aggregates spreading through cell-to-cell transmission of misfolded protein [52] [53] [54] , and aggregation intermediates are linked to ND [48, 55] .
␣Syn
assembling into highly soluble special oligomers may proceed to insoluble aggregates and plays a central role in ND in
Parkinson disease (PD) [56] ; it is potentially prone to misfold [57] and may lead to neuronal death, but other modes of toxicity have been proposed [58] , suggesting interaction of ␣Syn and A␤ resulting in ND [59] . The lysosomal protease cathepsin D influences ␣Syn processing, aggregation and toxicity in vivo [60] , and ␣Syn contributes to glycogen synthase kinase 3␤ catalysed phosphorylation in PD models [61] . Interaction with synphilin-1 promotes inclusion formation of ␣Syn providing new insights in to the inclusion body formation in Lewy body disorders [429] . Elevated levels of soluble ␣Syn oligomers have been detected in post-mortem brains of DLB patients [62] . Seeding induced by ␣Syn oligomers may lead to spreading of ␣Syn pathology [63] and to the formation of Lewy body (LB)-like intracellular inclusions [64] , with cell-to-cell transmission of ␣Syn aggregates via endocytosis, leading to nuclear fragmentation and caspase-3 activation [65] . NMR spectroscopy provided information about structure and aggregation of ␣Syn [66] . Methods to detect morphologically distinct oligomeric forms of ␣Syn have been described [67] .
In polyQ diseases, the protein context of expanded polyQ and its soluble mutant conformers are critical for the disease specificity [20] . Structural [69, 70] , whereas in sporadic amyotrophic lateral sclerosis (sALS) there is lack of evidence of monomer/misfolded SOD1 [71] . As most NDDs, ALS features deposits of SOD1, TARDBP and FUS aggregates.
and dynamic aspects related to oligomerization of superoxide dismutase 1 (SOD1) and its mutants have provided better insight into SOD1 pathway in relation to familial amyotrophic lateral sclerosis (fALS) [68], which is linked to the two genes TARDBP (TDP-43, which encodes TAR-DNA binding protein) and FUS (RNA binding protein fusion)
The discovery of new prions expands the spectrum of their biological functioning [72] . It further promotes the assembly of these pathological conformers into filaments that progressively accumulate in a disease-and protein-specific manner in the cytosol or nuclei of affected brain cells (neurons and/or glia) or in the extracellular space [16, 73] [124] , co-location of phospho-and ␣Syn in both neurofibrillary tangles (NFTs) and LBs [125] , and co-occurrence of abnormal deposition of , ␣Syn and TDP-43 in AD, DLB and other NDDs, probably related to genetic factors [118, 126] , highlight the interface between these two and other misfolded proteins. Oxidatively modified ␣Syn degraded by the proteasome promotes the recruitment of to protein inclusions in oligodendroglia cells in synucleinopathies [127] . Accumulation of A␤ and phosphoare thought to be coexistent, A␤ initiating hyperphosphorylation of [40] . Both can be linked by separate mechanisms driven by a common upstream driver [50] . Interactions between A␤, ␣Syn and may be a molecular mechanism in the overlapping pathology of AD and PD/DLB [128, 129] [137, 138] . Aggregated proteins are transported to perinuclear microtubule-organizing centres (centrosomes), where they are encapsulated by intermediary filaments to form aggressomes, subsequently subjected to proteolysis and removed by autophagy [139] . Ubiquitylation and endocytosis of plasma membrane proteins are regulated by Ub ligase adaptors [140] mediated by Ub ligase Ubr1 [141] . The proteasome also contains deubiquitinating enzymes that can remove Ub before substrate degradation initiates, thus allowing some substrates to escape degradation [142] . The [133, 147, 148] . p53 protein requires multiple layers of regulatory control to ensure correct functions [435] , and p53 proteasomal degradation may be Ubindependent [436] . The complexity of the Ub system in protein regulation and its role in the regulation of cell death are still not fully elucidated [149, 437] , but quantitative proteomics gave insight into the functionof unconventional Ub chains in proteasomal degradation [150] .
Inhibition of lysosomal functions by higher levels of chaperones reduces proteasomal activity [151] . Under conditions of proteolytic stress, the cell may switch to a non-proteolytic form of ubiquitination to help divert misfolded proteins away from an overloaded proteasome, and thus can preserve its proteasomal functions over prolonged periods of stress and recover thereafter [152] .
Many expanded proteins are resistant to proteolysis by the UPS, and the lack of its efficacy may be responsible for accumulating expanded proteins within affected cells, leading to neuronal inclusions. Ubiquitinated protein aggregates provide a nuclear centre for the formation of inclusion bodies, but there are several differences that distinguish these inclusions, some being aggregated in the cytoplasm, others are prevalent in the nucleus [105] . Differential activities of the UPS in neurons versus glia may account for the preferential accumulation of misfolded proteins [153] .
Misregulation of degradation of misfolded proteins leads to their accumulation with inhibition of axonal transport, thus facilitating the accumulation of ubiquitinated proteins in the cell body and cell dysfunction. This interaction may involve (1) a loss of function, (2) a gain of function or (3) an inflammatory stimulus.
Autophagy and neurodegeneration
Another pathway for cytosolic protein clearance and organelle degradation through lysosomes is autophagy [154] [155] [156] , a cytosolic, non-specific bulk degradation system, important as a clearance route for many cytosolic, aggregate-prone proteins. Model systems in increasing numbers are available to study the role of autophagy in the central nervous system (CNS) [154, 157] . Proteins are transferred to the lysosomal membrane and, through binding to a receptor lysosome-associated membrane protein (autophagosome), they are translocated into the lysosomal lumen and degraded [158] . Ub has a role in selective autophagy [139] . The molecular mechanism involved in the three autophagic pathways: chaperone-mediated autophagy (CMA), microautophagy (without vesicles) and macroautophagy, the most common type associated with mitochondria and cell death [159, 160] . [159, 161] . The autophagy machinery is regulated by different types of stress at various levels, from transcriptional activation to post-translation of protein modification [162] . Dysregulation of macroautophagy has been implicated in synaptic dysfunction, cellular stress and neuronal cell death [163] with superoxide being the major ROS regulator [164] , and contributes to the pathogenesis of several human diseases, including NDDs [158] , while its activation seems to be protective in certain NDDs [165] . The process, known as microautophagy, is poorly understood [166, 167] . Degradation of mutated ␣Syn by the CMA is impaired, which could explain the selective degeneration of PD dopaminergic neurons [168, 169] . The autophagy-related protein beclin-1 does not only play an important role in the intracellular degradation of ␣Syn either directly or indirectly through the autophagy pathway [170] , thus ameliorating the ND in ␣Syn models of PD, but also shows reduced expression in early AD [171] , while x-box-binding protein, a key UPR transcription factor that regulates genes involved in protein folding and quality control, protects against ALS by increasing autophagy [172] . Tissue-specific impairment of autophagy in the CNS tissue causes massive loss of neurons resulting in ND [173] . Emerging evidence supports the view that induction of autophagy is a neuroprotective process and that inadequate or defective autophagy, rather than excessive autophagy, compromises degradation of UPS substrates and, thus, promotes cell death [174, 175] . The UPS and autophagy are two signalling pathways that can provide protection against ND [138] . However, how autophagy protects cells from damage leading to ND is not yet clear [176, 177] .
Macroautophagy is responsible for clearing of aggregated or aggregate-prone proteins, microautophagy for degradation of organelles, and CMA uses the lysosomal protein LAMP2a as a receptor that recognizes proteins with a specific pentapeptide for lysosomal degradation. Their relevance in ND has been reviewed recently
UPS in neurodegenerative disorders
Dysregulation in the UPS appears to be both a cause and a result of ND processes. Its dysfunction has already been implicated in the pathogenesis of PD [178, 179] , and the demonstration that ␣Syn is degraded by both proteasome and autophagy indicates a possible linkage between the UPS and ALP [168] . Mutated ␣Syn inhibits ALP by binding to the receptor on the lysosomal membrane for autophagy (Greek: self-digestion) pathway supporting the assumption that the ALP may be related to the development of PD [180] . LBs [439] . There is conflicting evidence concerning the pathogenesis of ␣Syn aggregation [66] . A functional Ub- [184, 185] , display variable neuropathology, including ␣Syn and inclusions [186, 187] , thus suggesting an upstream role of LRRK2 in protein aggregation [188] . The role of UPS pathology in AD has been reviewed [133, 189] . A␤ inhibits the proteasome and enhances amyloid and accumulation [190] , but proteasome inhibition increases accumulation and insolubility of protein independent of phosphorylation, and JNK inhibition may be partially responsible for the relatively decreased phosphorylation of in tg models [191] . ATPase subunit 6b (S6b) transcript up-regulation may be related to tauopathies, while in synucleinopathies it appears not to be involved [192] .
3-ligase complex consisting of early-onset familial PD associated Parkin, PINK-1 (PARK-6) and DJ-1 (PARK-7) mutations promotes degradation of un-or misfolded proteins and may constitute a pathogenic mechanism for recessive forms of inherited PD [81, 183]. LRRK2 mutations (PARK8), a major cause of late inset parkinsonism, have clinical features comparable to sporadic PD
The importance of decreased UPS function has been observed also in other NDDs, e.g. in HD, where protein quality control regulates polyQ-induced toxicity [20], but its global status in HD brain
is not yet fully elucidated [193] . Neuronal polyQ protein inclusions are present predominantly in the nucleus, which is not accessible to autophagy. Intracellular degradation of polyQ aggregates by the UPS is triggered by some nuclear Ub ligases [194] , and inclusion bodies are suggested to have a protective cellular response to mhtt mediated by improving intracellular protein degradation [195] , while UPS activity in synapses of HD is impaired [196] . [197] [203, 205] . Generation of excessive nitric oxide and ROS can mediate protein misfolding in the absence of genetic predisposition [206] . Among the various free radicals generated in the living organism, hydroxyl radical and peroxynitrite are the most potent and can damage cells via nonselective oxidation of proteins, lipids, fatty acids and nucleic acid [204] [203] .
Dysfunction of the UPS is also important in ALS showing skein-like inclusions in motor neurons rich in Ub proteasome and some chaperone proteins, in SCAs, with neuronal intranuclear inclusions containing ataxin-1 and several chaperones
Proteins are initial targets of ROS, and protein radicals generated by ROS can oxidize reduced glutathione, which triggers dysregulation of calcium homeostasis, reactive astrogliosis and other changes observed in ND [207, 208] . Superoxide (O 2Ϫ ) is suggested to be the major reactive OS regulating autophagy [164] [209] . [210] . Oxidative damage to nuclear and mitochondrial DNA (mtDNA) occurs in the earliest detectable phase of AD, PD and HD, but also in normal aging [202, 204, [211] [212] [213] . Although [440] . Conditions such as neuroferritinopathy [217] and Friedreich ataxia are associated with mutations in genes that encode proteins involved in iron metabolism [218] , inducing OS and cell death [441] the brain ages, iron accumulates in regions that are affected by AD and PD [219] , and dopamine (DA) complexes of iron are important in the pathogenesis of PD [220] . [227] ; and contribution of AGE receptors (RAGE) to A␤ cytotoxicity [228] , while infusion of soluble RAGE in tg animals decreases A␤ content and amyloid load [225] . Oxidative imbalance is met by a series of complex reactions (mitochondrial dysfunction, impaired synaptic transmission, disruption of membrane integrity, etc.) to establish a disease-related homeostasis balance [204] . Excess A␤ may induce OS and/or disturb cellular calcium homeostasis through disproportionate PrPC-receptor crosslinking, but the precise mechanism between mitochondrial oxidative damage and the role of oligomeric A␤ has not yet been explicated [229] . Oxidative damage to DNA and RNA repair is particularly severe in the hippocampus, the earliest and most severely involved brain area, and nitrated brain proteins are seen in both early and late stages of AD [230] . In AD RNA is extensively modified and, while clearly damaged, its rapid turnover may also serve a protective function [204] . Stress-activated protein kinase pathways triggered by OS, are excessively activated in AD, even in early stages, deregulating cyclin-dependent kinase 5, compromising the cellular antioxidant defence system and causing mitochondrial damage [231] . S-nitrosylation of dynamin-related protein 1 (Drp1) that is increased in AD brains, mediates A␤-related mitochondrial fission and neuronal injury [232] . Antioxidants may protect neurons in AD and PD, reducing the risk of ND [233] . [253, 257] . Disturbances of the mitochondrial proteolytic system affect neuronal maintenance and axonal function [444] . In NDD, there is a reciprocal interaction between mitochondrial fusion, fission, transport and mitophagy [258] . Impaired bioenergetics and dysfunction of mitochondrial energy metabolism lead to reduced ATP production, impaired calcium buffering and generation of ROS, representing a 'deadly triad in ND' [259] . Mitochondrial dysfunction initiates and propagates neuronal dysfunction in all age-associated NDDs [445] .
Increased levels of oxidative damage to DNA, lipids and proteins have been detected in post-mortem tissues from patients with PD, AD, ALS, progressive supranuclear pals (PSP) and aging, some of which are environment-induced
Oxidative stress in Alzheimer disease
Oxidative stress in Parkinson disease
In a variety of tissues, cumulative OS, disrupted mitochondrial respiration and oxidative mitochondrial damage are associated with, and may promote cell death [203, [253] [254] [255] 259] [261] , that directly and indirectly impairs mitochondrial function [262] .
OXPHOS disorders ranging from Leigh disease to PD and AD are caused by defects of mitochondrial energy metabolism, related to complex I deficiency [263] . There are several pathways by which both mitochondrial dysfunction and protein aggregation may interact (Fig. 4) [265, 266] . A consequence of mitochondrial dysfunction is increased generation of free radicals and oxidative damage [254] . A decrease in the DNA base excision repair activity in NDDs suggests that that the brain might be subjected to the double insult of increased DNA damage, as well as deficiencies of DNA repair pathways [267] [268] [269] . There is evidence of impaired DNA repair in both the aging brain and AD [270] . [268] . [273] [274] [275] [276] .
The importance of microRNAs, brain-enriched, small non-coding RNAs that participate in RNA translational and protein expression regulation, has been emphasized [272], suggesting their involvement in the emergence or progression of NDDs, including AD and prion-induced NDD
Mitochondrial dysfunction in Alzheimer and Parkinson disease
In AD, there is a large body of evidence implicating impaired energy metabolism and oxidative damage [see 204, 209] [277, 278] . Significant increase in oxidative damage to mtDNA in AD brain may cause abnormal mitochondrial dynamics and dysfunction that ultimately damage AD neurons [279] . A␤ plays a role in the formation of mitochondrial permeability transition pore (mPTP) [446] . A␤-induced mitochondrial dysfunction is an early event in AD tg models [280] and is a trigger of AD pathophysiology [447] . [448] . Despite the evidence of mitochondrial dysfunction in AD, no causative mutations in the mtDNA have been detected so far, and results of studies on the role of mtDNA haplogroups in AD are controversial, although a primary role of the mitochondrial genome is suggested [278] . Both APP and ␥-secretase, as well as an isoform of insulin-degrading enzyme, which regulates A␤ levels, are present in mitochondria [224] , and mitochondrial OS causes hyperphosphorylation of [281] . Mitochondrial dysfunction in AD is caused by oligomeric A␤ [449] , leading to impairment of ATP production and increase of OS. It may also be caused by impaired axonal transport with proximal collection of mitochondria which could contribute to loss of distal synapses [282] . Calcium dysregulation occurring early in AD, related to PSEN mutations, A␤ production and tau phosphorylation [450] leads to synaptic and neuronal dysfunction, underlying dementia associated with the disease [451] . Caspase-cleaved expression results in mitochondrial dysfunction in cortical neurons via increased calcineurin activity in AD brains [283] . Significant increase in oxidative damage to mtDNA in AD brain may cause abnormal mitochondrial dynamics and dysfunction that ultimately damage AD neurons [279] . Mitochondrial ATP synthase in the entorhinal cortex is a target of OS in the first, clinically silent periods of AD pathology [284] .
Patterns in protein changes in early AD suggest activation of mitochondrial pathways that include proteins responsible for transport and utilization of ATP. The most prominent changes may occur in early AD
Mitochondrial alterations and OS are important parts of the multifactorial pathogenic process of PD [267, [285] [286] [287] [288] 452] [289] [290] [291] [292] [293] and regulates DNA repair [294] , while PINK1 (PARK6), a fPD-associated gene, modulates mitochondrial morphogenesis and distribution [295] . Both are causes of autosomal recessive PD and induce the autophagic pathway (mitophagy) or defective oxidative phosphorylation [454, 455] .
. In both sPD and fPD, abnormal mitochondrial paradigms include impaired function of the electron transport chain, damage to mtDNA, impaired calcium buffering, and anomalies in mitochondrial morphology and dynamics. Mitochondrial dysfunction triggers an increased free turbulin, which destabilizes the microtubule network and promotes ␣Syn oligomerization [453]. Since the UPS requires ATP at several steps, impaired mitochondrial function may impair its activity. More importantly, increased production of ROS leads to damaged misfolded proteins requiring degradation by the UPS. Parkin plays a role in maintaining mitochondrial homeostasis [289]. It improves mitochondrial dysfunction, alters the intrinsic threshold for mitochondrial cytochrome c release, regulates their remodelling, promotes their autophagy, promotes DNA repair and protects against genotoxicity, promotes intracellular A␤42 clearance
A specific protein-protein interaction of ␣Syn and COX, a key enzyme of the mitochondrial respiratory chain, suggests that ␣Syn aggregation may contribute to enhanced mitochondrial dysfunction [296] . [297] . Both rotenone and chronic MPTP result in oxidative damage [298, 299] [304] . [305, 306, 456] , and in models of Machado-Joseph disease, decreased synthesis of the protein Hsp27 and increased mitochondrial DNA damage are seen [307, 308] . Mitochondrial dysfunction has been linked to the ALS variants of SOD1 which is preferentially associated with mitochondria and subsequently impairs mitochondrial function [457] via the mitochondrial permeability transition pore (mPTP) [458] . [315] [316] [317] . Slow transport is a function of neuronal intermediate neurofilaments [318] . For intracellular transport which is fundamental for cellular functions, survival and morphogenesis, the kinesin superfamily transport proteins are important [319] . Neurofilament light chain head domain phosphorylation regulates axonal transport of neurofilaments [315] . [320] . The main pathogenic stimuli of these conditions, though often not definitely determined, result in an initial perturbation of the axon and its cytoskeleton, which then results in slow neuronal degeneration and loss of connectivity [312] . [313] .
Acute action of rotenone induces mitochondrial ROS production disrupting Ca 2ϩ homeostasis in SNc but not in substantia nigra pars reticulata (SNr) neurons
For clarification of NDDs with genetic causes of bioenergetic deficits see [1]. Energetic defects in major NDDs only in part have been proven by the identification of genetic defects that are causally linked to mitochondrial dysfunction. If this has a causative role to disease pathogenesis, then a number of therapeutic targets are implicated, including the permeability transition pore, cytochrome c release, free radical scavengers that could result in novel treatments. Mhtt causes calcium homeostasis and mitochondrial dysfunction in striatal neurons and excitotoxic neuronal death
Fragmentation of neuronal Golgi apparatus
Fragmentation of the neuronal Golgi apparatus-probably a secondary effect of the above mentioned basic mechanisms -was reported in ALS, corticobasal degeneration, AD, PD, CreutzfeldtJakob disease, and in SCA type 2 (SCA2) [309]. Mechanisms involved in Golgi fragmentation include: (i ) dysregulation by mutant SOD1 of the microtubule-destabilizing protein Stathmin, (ii ) disruption by mutant SOD1 of the neuronal cytoplasmic dynein, (iii ) coprecipitation of mutant SOD1 with Hsp25 and Hsp27, (iv ) reduction of detyrosinated microtubules by aggregated which resulted in non-apoptotic cell death and (v ) disruption by mutant growth hormone of the trafficking from the rough ER to the Golgi apparatus [310]. ␣Syn has been shown to block ER Golgi traffic causing Golgi fragmentation and neuronal Golgi fragmentation is an early and probably irreversible lesion in ND in nigral neurons with ␣Syn ϩ inclusions in PD [311], caused by a variety of mechanisms including accumulation of misfolded proteins.
Disruption of cellular/axonal transport
Three mechanisms highlight the significance of disrupted cellular/axonal transport in human NDDs: (i ) human motor protein mutations in these disorders, (ii ) axonal transport defects in animal and in vitro cellular models harbouring human mutations and (iii ) roles for pathogenic proteins like APP, , presenilin and synuclein, in the regulation of axonal transport
Mitochondrial transport in axons uses motors of kinesin families and cytoplasmic dynein, to translocate along microtubules, and bidirectional movement may be coordinated through interaction between dynein and kinesin-1. Protein defects that are directly or indirectly linked to axonal transport could be reversed by specific interventions stabilizing microtubules and repair or protect axons. The axonal transport of occurs via a mechanism utilizing fast transport motors, including the kinesin family of proteins, and that ␣Syn transport in neurons may involve both kinesin and dynein proteins
Axonal transport in tauopathies
Axonal transport is impaired in AD and other tauopathies [321, 322] , probably early in their pathogenesis. Proteolytic cleavage of APP occurs before its sorting into axonal transport vesicles [323] .
It travels via fast axonal transport and in vesicular complexes containing presenilin and ␤-site APP-cleaving enzyme 1 (BACE1) and acts as a receptor for the anterograde motor kinesin. Decreased retrograde transport of nerve growth factor (NGF) in human brain
and mouse models leads to loss of neuronal markers and shrinkage of neurons in the cholinergic basal forebrain, rather than due to decreased synthesis. Misregulation of APP can transduce into misregulation of fast axonal transport, which is a pathogenic mechanism for intraneuronal A␤ [324] . There are multiple initiating factors converging upon pathways of amyloid induced defects in neuronal transport [325] . , is a microtubule-binding protein that, after its hyperphosphorylation and segregation into tangles, is unable to bind microtubuli, causing their destabilization and, thereby, disrupting axonal transport movement. The 3-and 4-repeat proteins show differential effects on mitochondrial axonal transport [326] . Interfering with axonal transport may activate stress kinase pathways initiating a biochemical cascade that drives normal proteins into a pathogenic state [327] . However, axonal transport rates in vivo are unaffected by deletion, or hyperexpression, in mice [328] . [329] . Accumulations of small ␣Syn aggregates in presynaptic terminals in the cortex of DLB and PD associated with loss of dendritic spines suggest a pathological impact on synaptic functions leading to ND, implicating PD as a synaptopathy [330] . [331] . Mutant SOD1 interfering with axonal transport and protein turnover may influence the function and viability of motor neurons in ALS [332] . [193] [333] .
Axonal transport in synucleinopathies ␣Syn is a highly conserved protein, strongly expressed in neurons and enriched in presynaptic terminals. It is mainly transported in the slow, but a part also in fast transport. Significant age-related transport retardation may lead to accumulation of ␣Syn over time and produces pathology suggesting axonal transport abnormalities in synucleinopathies
Axonal transport in other neurodegenerative diseases
In SOD-1 tg models of ALS show retarded transport of neurofilament proteins and deficits in the delivery of mitochondria to the axon by fast transport, even before symptom onset implicated impaired transport as an early defect in the progress of ND, but, to date, no motor protein gene mutation in human ALS has been reported
HD shows striatal degeneration with aggregation of huntingtin (htt) within vesicles and moves in the fast axonal transport component. In animal models, this was inhibited by infusion with pathological polyQ repeats and by disruption of the Drosophila htt gene. Htt plays a role in protein trafficking, vesicle transport, postsynaptic signalling, transcriptional regulation and apoptosis. A loss of function of the normal protein and a toxic gain of function of mhtt contribute to the disruption of multiple intracellular pathways
Dysfunction of neurotrophins
There is growing evidence that reduced neurotrophic support is a significant factor in the pathogenesis of NDDs [334] [201] [335] . AD brain shows increase of the precursor form of NTF and decrease in BDNF in surviving neurons of hippocampus and neocortex, and decrease of TrkA in cortex and nucleus basalis [321] . A␤ may induce the TrkA pathway activation and promote NGF secretion [336, 337] . A␤ may act as a neurotrophic factor that mimics the activity of NGF. However, at higher concentrations, the amyloid behaves as an antagonist of NGF, contributing to the advent of AD [338] . A␤42 may induce neuronal death through the p75 NTF receptor, and p75-A␤-PrPC complexes could provide reactive OS and elevated intracellular calcium required for p75 signalling [339] . Postmortem studies point to a lack of NGF action in early AD stages, whereas NGF is found in enhanced concentrations in brains with severe AD partly due to a pathologically altered axonal transport of NGF in the neurons [340] . Advanced glycation and lipoxidation end-products modification of pro-NGF offers a novel pathway in the etiopathogenesis of AD [459] . Inhibition of soluble NTF signalling in a mouse model of AD prevents/slows pre-plaque amyloid-associated neuropathology, and potentially the progressive neuron 'loss' in AD [341, 342] . [344] . Protectional effects of BDNF on cortical neuronal circuitry involving AD, acting through amyloid-independent mechanisms [345] , indicate a prominent role of NGF in both the aetiology and treatment of AD [346] .
; it can cause down-regulation of NTFs which, in turn, up-regulates antioxidant enzymes and promotes the expression of antioxidant proteins. Brain-derived neurotrophic factor (BDNF) levels in tg mouse models of AD are negatively correlated with A␤ levels, suggesting that the effect of A␤ on decreased BDNF expression is specific to the aggregation state of A␤ and is dependent on large oligomers
New steps and targets in the pathogenesis of AD may be: NGF and BDNF signalling through neurotrophic tyrosine kinases prevent the cleavage of APP by BACE1, which, together with ␥-secretase, converts APP into toxic forming A␤ fragments, and a soluble N-terminal fragment (N-APP). In AD, this extracellular fragment of APP, and death receptor G may engage tumour necrosis factor (TNF) receptor family member 21 (TNFRSF21) which activates a widespread caspase-dependent self-destructing process -via activating caspase-6 apoptosis-related cystein peptidase (casp6, MCH2)-related enzymes-as a major culprit behind AD
In [201, 345] . [348] . Iron has various pro-and anti-inflammatory activities, and inappropriate iron chelation may be a major pathogenic contributor to inflammatory and NDDs [349] . AD 'inflammation' has been considered toxic or, on the contrary, useful [350] . However, a better knowledge about the interplay between the nervous system and the local and systemic immune system will be important for the understanding of pathogenic mechanisms of ND [351] , the role of innate 'protective autoimmunity' and of reparative functions of autoimmunity in NDDs [352] . It has been suggested that immune alterations may occur prior to amyloid deposition and neuronal degeneration. Complement activation exacerbates the pathology of AD, and it has been discussed whether it could be the outcome of the innate immunity defence in the brain [353] . A central question is whether immune and inflammatory pathways become hyperactivated with age and promote ND or whether insufficient immune responses, which fail to cope with age-related stress, may contribute to NDDs [354] . Age-related neuroinflammatory changes negatively impact neuronal function [460] . Breakdown of the normal blood-brain barrier with influx of blood-born molecules (plasma proteins) have been suggested to cause local damage as starting mechanisms of some NDDs [348] . A leaky BBB, fibrinogen infiltration and microglial activity may cause neuronal damage in 'inflamed' AD brain [461] .
'Neuroinflammatory' processes
Chronic inflammatory reactions and signs of immune activation in the CNS, with major histocompatibility complex (MHC) class II expression, glial reaction, T-cell infiltration, and blood-brain barrier dysfunction are prominent pathological features in the pathogenesis and progression of NDDs
Activated microglia may be both neurotoxic and neuroprotective, depending on several factors including aging, but the causes for transformation between the two actions remains largely unknown [355] [356] , while astrocytes produce anti-inflammatory and neuroprotective agents [357] . [358] . The patterns of cytochemokine involvement strengthen the inflammatory theory of AD and raise a pathophysiological role for selective alteration of this network [359] . Footprints of radicals and peroxynitrite attack have been detected in post-mortem AD brain, which, at least in part, are produced by activated microglia, and, together with anomalous release of cytokines and chemokines, but also systemic inflammation with increase in serum TNF␣, may be a progression factor in AD [350, 360, 361] . In both aged and AD brain and in animal models, deposition of A␤ is likely to trigger inflammatory cascades with increased production of pro-inflammatory factors, part of which are localized in the A␤ plaques and in the surrounding activated glia [355] . Inflammation potentially increases brain levels of A␤ by three mechanisms: increased influx, decreased efflux, and increased neuronal production [362] . JNK-AP1 signalling pathway may be responsible for A␤-induced neuroinflammation in cultured human brain endothelial cells and AD brain and this signalling pathway may serve as a therapeutic target for relieving A␤-induced inflammation [363] , and TNF␣ gene polymorphism may affect the risk of developing AD [364] . A␤ oligomers and fibrils stimulate differential activation of microglia [358] . Inactivation of pro-inflammatory cytokines such as TNF, despite known adverse effects, makes it an attractive target for therapeutic development to treat NDDs [365] . Inhibiting p53 pathways in microglia alternates microglial evolved neurotoxicity following exposure to Alzheimer peptides [462] . The problems of AD and tg animal models treated by immunotherapy causing plaque removal and increase in severity of cerebral amyloid angiopathy, but not preventing progressive ND, are not discussed here [see [366] [367] [368] .
Components related to AD neuroinflammation include microglia and astrocytes, the classic and alternate pathways of the complement system, the pentraxins, acute-phase proteins, neuronal-type nicotinic acetylcholine receptors, peroxisomal proliferation-activated receptors, as well as 'pro-inflammatory' cytokines and chemokines. In animal models and human brains, both the microglia and astrocytes may generate A␤, which itself may act as a pro-inflammatory agent inducing the activation of glia and many inflammatory components
On the other hand, in human AD brain deposits of A␤ devoid of ϩ structures were found to be co-localized with non-activated, ramified dystrophic microglia suggesting that A␤ does not trigger microglial activation [369] . These findings and recent experimental evidence [370] argue against the hypothesis that neuroinflammatory changes contribute to AD. They support the idea that progressive, age-related microglial degeneration and loss of microglial neuroprotection rather than induction of microglial activation contribute to the onset of sporadic AD [369] .
In PD, SN cell degeneration is accompanied by astroglial reaction and proliferation of MHC class II positive microglia releasing pro-inflammatory cytokines, nitric oxide, complements, and OS that may be both inducing factors or sequelae of neuronal death [371, 463] 
. The pattern of humoural immune reactivity is consistent with activation of microglia leading to the targeting of DA nigral neurons for the destruction in both idiopathic and genetic cases of PD [372]. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration, while human neuromelanin induces neuroinflammation and degeneration in the rat SN [373], and aggregated ␣Syn activates microglia. DA cell death is probably influenced by the innate immune system, and in an MPTP mouse model T cell-mediated DAergic toxicity is almost exclusively arbitrated by CD4
ϩ T cells and requires the Fas/FasL but not the IFNc cytotoxic pathway [374] . Intrastriatal lipopolysaccharide injection served as a model for inflammatory-induced mitochondrial dysfunction causing NDD in the nigrostriatal system [375] . Microglial activation and corresponding DAergic terminal loss in early PD support the notion that neuroinflammatory responses by intrinsic microglia contribute to the progressive degeneration in PD and related diseases [376] . Part of the specific vulnerability of the SN could be a consequence of h-TNF␣ hypomethylation [377] , TNF␣ overexpression inducing apoptosis of neuronal cells. On the other hand, microglia may be affected by the disease process and may therefore not be capable of exerting sufficient neuroprotective function, such as glutathione peroxidase expression [241] . Microglia activation in HD has been shown to correlate with severity of the disease [378] , with a close spatial and temporal relationship to neuronal dysfunction, and has already been detected in presymptomatic HD gene carriers [379] . BDNF and its receptor levels have been assessed in human cortices affected by HD [347] . Alterations of the adaptative immune system in sALS suggest early involvement of a 'neuroinflammative' process in the pathobiology of ALS [350, 380] . The role of inflammation in tg models of NDDs, in particular in mouse models of AD, have been reviewed recently [381] . In conclusion, whereas recent studies provide evidence for microglial abnormalities in several NDDs including ALS, HD and Creutzfeldt-Jakob disease [382, 383] , the involvement of microglia in the pathogenesis of AD and PD remains controversial [369, 384] . [388] , which exhibits rapid cell swelling and subsequent rupture of the plasma membrane that, due to an inflammatory response, usually induces substantial secondary cell damage in the surrounding tissue [389] . Autophagy (PCD type II), known as the process by which molecules and organelles undergoe lysosomal clearance/degradation in order to help maintain cellular homeostasis [160] , also depends on caspase activation and a number of autophagy-related proteins and genes such as LC3 (light chain 3) and beclin-1 [171, 172] . Hundreds of caspase substartes have been described but only for a few of them the function of their cleavage by caspasin is well understood in the pathogenesis of NDDs [390] . There are many reasons and ways for a neuron to die, among which apoptosis is a specific form that is processed in two major signalling pathways, the extrinsic (death receptor) pathway and the intrinsic (mitochondria based) pathways, with several avenues of cross-talk between them (Fig. 5) .
The final pathway: multifaceted neuronal death
Many of the morphological differences between apoptotic and necrotic processes are thought to be a consequence of the action of cysteine proteases, while caspase and calpain functions in cell death are bridging the gap between apoptosis and necrosis. However, caspase-independent cell death also exists [388] . Tissue-specific impairment of autophagy in CNS tissue causes massive loss of neurons resulting in ND. Autophagic cell death, more correctly cell death with autophagy rather than by autophagy [391] , probably represents a failure of neuroprotective mechanisms [392] . 
Cell death cascades in major NDDs
Despite demonstration of DNA fragmentation and up-regulation of pro-apoptotic and cell death regulator proteins, it is still unclear, whether apoptotic or necrotic modes are responsible for cell death in NDDs. It is preceded by the activation of caspases and altered expression of pro-apoptotic members of the Bcl-2 family and [245] ). [410] [411] [412] . Such glial perturbations (non-cell-autonomous) are thought to apply in several NDDs [413] . The heterogeneous astroglial responses in various synucleinopathies, tauopathies and other NDDs indicate distinct underlying pathogenic mechanisms in each disorder [414] , while in other diseases, e.g. MSA, there is a definite relation between oligodendrogliopathy and neuronal degeneration [415, 416] . While astrocytic dysfunction could play its part in the progression and severity of AD [417] , the role of astrocytes in PD, ALS and related disorders is poorly understood [414, 418, 419] [2, 91, 133, 154, 198, 201, 254, 366, 405, 423] . An extensive discussion of effective prophylactic and treatment strategies appears to be outside the goal of the present review. 17 
Fig. 6 Diverse pathways leading to cell death, illustrated by the concept of the apoptosis-necrosis continuum that integrates the various death pathways and subsequent intracellular signalling pathways (ER stress, UPS, ATP loss, etc.) to help explain the complex patterns of neuronal death (mix of PCD-types I, II and /or III) (modified from
